,18 A recent meta-analysis also shows that the resolution of MASH and fibrosis by FGF21 analogs is superior to resmetirom and glucagon-like peptide 1 analogs.19 Here, FGF21 is linked to metabolic dysfunction-associated steatohepatitis.